-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma

Sponsor: Sanofi Genzyme
Program: Product Theaters
Sunday, December 6, 2020: 11:00 AM-12:00 PM
An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma

Megan Sell, NP

Sanofi Genzyme, Cambridge, MA
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>